● Recruiting

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Condition: Peripheral Arterial Disease · Atherosclerosis of Extremities · Inflammation · Sponsor: Population Health Research Institute

PhasePhase 3

Planned participants6150

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral artery disease.

This description comes directly from the study's public registry record.

Talk to the study team

Noel C Chan, MD · 905-521-2100 · Noel.Chan@TAARI.CA

Jessica Tyrwhitt · leaderpad@phri.ca

Always discuss trial participation with your own doctor first.

Locations (70)

Yale School of Medicine	New Haven, Connecticut, United States	Recruiting
University of Florida - Gainesville	Gainesville, Florida, United States	Recruiting
Tampa General Hospital	Tampa, Florida, United States	Recruiting
University of Chicago Medical Center	Chicago, Illinois, United States	Recruiting
Henry Ford Health System	Detroit, Michigan, United States	Recruiting
Mayo Clinic	Rochester, Minnesota, United States	Recruiting
Rutgers University	Newark, New Jersey, United States	Recruiting
University of North Carolina at Chapel Hill	Chapel Hill, North Carolina, United States	Recruiting
Duke Regional Hospital	Durham, North Carolina, United States	Recruiting
Duke University Medical Center	Durham, North Carolina, United States	Recruiting
Duke Raleigh Hospital	Raleigh, North Carolina, United States	Recruiting
Ohio State University Wexner Medical Center	Columbus, Ohio, United States	Recruiting

+ 58 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04774159